Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients

PHASE1/PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

September 30, 2015

Conditions

Diabetic Foot Ulcers

Interventions

DRUG

Selinexor

Topical gel

OTHER

Standard-of-Care

Surgical debridement, sterile saline rinses, and dressing changes.

OTHER

Vehicle Gel

Topical vehicle gel with no active ingredients.

Trial Locations (1)

South Pacific Clinical Trials, Auckland